Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.71 USD
Change Today 0.00 / 0.00%
Volume 0.0
IMSC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

implant sciences corp (IMSC) Key Developments

Implant Sciences Corp. Announces Resignation of Directors

On April 23, 2015, each of John J. Hassett, Howard Safir and Michael C. Turmelle and, on April 25, 2015, John A. Keating, notified Implant Sciences Corporation of his refusal to stand for re-election to the Board of Directors of the company at the company's next annual meeting of shareholders. Each of these directors has notified the company that his refusal to stand for re-election is not based on any disagreement with the company.

Implant Sciences Corporation Receives Order for 75 QS-B220 Explosives Trace Detection Systems in the Netherlands

Implant Sciences Corporation reported that it has received an order for 75 QS-B220 explosives trace detection systems in the Netherlands. The systems are expected to be delivered in the company's fourth fiscal quarter and will be used for screening passengers and baggage in an airport environment. The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

Implant Sciences Receives Order for 66 Explosives Trace Detection Systems in Norway

Implant Sciences Corporation reported that the Company has received an order for 66 QS-B220 explosives trace detection systems in Norway. The systems, many of which have already been shipped, are scheduled to be deployed for passenger and baggage screening in an airport environment. The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

Implant Sciences Corp. Ships $750,000 of Explosives Trace Detector Systems to Asia

Implant Sciences Corp. reported the shipment of more than $750,000 in explosives trace detection systems to various customers in Asia. The shipments include a mixture of QS-H150 and QS-B220 systems, and will be deployed in military, aviation security, and critical infrastructure protection applications. The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

Implant Sciences Extends Credit Agreements with DMRJ Group, LLC

Implant Sciences Corp. announced the extension of its March 2014 secured credit agreements with DMRJ Group, LLC and the group of investors represented by BAM Administrative Services, LLC. DMRJ has agreed to extend the maturity of all Implant Sciences indebtedness held by DMRJ from March 31, 2015 to March 31, 2016. No other terms or conditions of the DMRJ credit agreements were changed. The maturity of the BAM note has been extended from March 31, 2015 to March 31, 2017. As of April 1, 2015, in consideration of the two year extension, the interest rate on the BAM note will increase by 1%. The remaining terms and conditions of the BAM credit agreement remain the same.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMSC:US $0.71 USD 0.00

IMSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bruker Corp $19.64 USD +0.105
CR Bard Inc $170.98 USD +1.42
Safran SA €65.18 EUR -0.07
Thermo Fisher Scientific Inc $128.45 USD +0.79
View Industry Companies
 

Industry Analysis

IMSC

Industry Average

Valuation IMSC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPLANT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.